Rest and exercise cardiovascular effects of terazosin in congestive heart failure. 1990

R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
Department of Medicine (Cardiovascular Division), Ohio State University, Columbus.

This study investigated the acute effects of the alpha 1 antagonist terazosin on myocardial circulatory responses at rest and during exercise. Ten patients with congestive heart failure (class III and IV) underwent hemodynamic evaluation before and after a 5-mg oral dose of terazosin. At rest and during exercise, terazosin significantly decreased pulmonary capillary wedge pressure, systemic vascular resistance and mean arterial pressure while cardiac index increased. Stroke volume index increased (p less than 0.01) during exercise while left ventricular stroke work index remained unchanged in both experimental conditions. Terazosin administration significantly decreased both rest and exercise myocardial oxygen consumption while exercise coronary sinus oxygen content increased and arterial-coronary sinus oxygen difference diminished (p less than 0.05). Parallel with these changes, alpha blockade decreased the ratio of coronary blood flow to total cardiac output. Coronary vascular resistance remained unaltered with alpha blockade both at rest and during exercise. Coronary blood flow tended to diminish with decreased myocardial oxygen demand. Alpha 1 blockade induces systemic vasodilation and improves myocardial circulatory parameters without inducing coronary dilation or altering metabolic autoregulation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D012146 Rest Freedom from activity. Rests
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
June 1993, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
January 1982, Acta medica Scandinavica,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
April 1982, British heart journal,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
November 1984, Circulation,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
August 1999, The American journal of cardiology,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
September 1986, The American journal of cardiology,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
January 1987, Pharmacotherapy,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
May 1993, European heart journal,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
October 1993, Scandinavian journal of clinical and laboratory investigation,
R D Magorien, and S Sinnathamby, and C V Leier, and H Boudoulas, and D V Unverferth
July 1980, Revista medica de Chile,
Copied contents to your clipboard!